Dobutamine stress echocardiography: a sensitive indicator of diminished myocardial function in asymptomatic doxorubicin-treated long-term survivors of childhood cancer
SE Klewer,
SJ Goldberg,
RL Donnerstein,
RA Berg,
and
JJ Hutter Jr
University of Arizona College of Medicine, Tucson 85724.
Doxorubicin is an effective anticancer chemotherapeutic agent known to cause acute and chronic cardiomyopathy. To develop a more sensitive echocardiographic screening test for cardiac damage due to doxorubicin, a cohort study was performed using dobutamine infusion to differentiate asymptomatic long-term survivors of childhood cancer treated with doxorubicin from healthy control subjects. Echocardiographic data from the experimental group of 21 patients (mean age 16 +/- 5 years) treated from 1.6 to 14.3 years (median 5.3) before this study with 27 to 532 mg/m2 of doxorubicin (mean 196) were compared with echocardiographic data from 12 normal age-matched control subjects. Graded dobutamine infusions of 0.5, 2.5, 5 and 10 micrograms/kg per min were administered. Echocardiographic Doppler studies were performed before infusion and after 15 min of infusion at each rate. Dobutamine infusion at 10 micrograms/kg per min was discontinued after six studies secondary to a 50% incidence rate of adverse symptoms. The most important findings were that compared with values in control subjects, end-systolic left ventricular posterior wall dimension and percent of left ventricular posterior wall thickening in doxorubicin-treated patients were decreased at baseline study and these findings were more clearly delineated with dobutamine stimulation. End-systolic left ventricular posterior wall dimension at baseline for the doxorubicin-treated group was 11 +/- 1.9 mm versus 13.1 +/- 1.5 mm for control subjects (p less than 0.01). End-systolic left ventricular posterior wall dimension at the 5-micrograms/kg per min dobutamine infusion for the doxorubicin-treated group was 14.1 +/- 2.4 mm versus 19.3 +/- 2.6 mm for control subjects (p less than 0.01).(ABSTRACT TRUNCATED AT 250 WORDS)
This article has been cited by other articles:
|
|
|
|
 
D. E. Thomas, R. Wheeler, Z. R. Yousef, and N. D. Masani
The role of echocardiography in guiding management in dilated cardiomyopathy
Eur J Echocardiogr,
December 1, 2009;
10(8):
iii15 - iii21.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Developed in Collaboration With the European Heart, D. P. Zipes, A. J. Camm, M. Borggrefe, A. E. Buxton, B. Chaitman, M. Fromer, G. Gregoratos, G. Klein, A. J. Moss, et al.
ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death--Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death)
J. Am. Coll. Cardiol.,
September 5, 2006;
48(5):
1064 - 1108.
[Full Text]
[PDF]
|
|
|
|
|
|
|
Developed in Collaboration With the European Heart, D. P. Zipes, A. J. Camm, M. Borggrefe, A. E. Buxton, B. Chaitman, M. Fromer, G. Gregoratos, G. Klein, A. J. Moss, et al.
ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death)
J. Am. Coll. Cardiol.,
September 5, 2006;
48(5):
e247 - e346.
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. P. Zipes, D. P. Zipes, A. J. Camm, M. Borggrefe, A. E. Buxton, B. Chaitman, M. Fromer, G. Gregoratos, G. Klein, A. J. Moss, et al.
ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death--executive summary: A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society.
Eur. Heart J.,
September 1, 2006;
27(17):
2099 - 2140.
[Full Text]
[PDF]
|
|
|
|
|
|
|
Writing Committee Members, D. P. Zipes, A. J. Camm, M. Borggrefe, A. E. Buxton, B. Chaitman, M. Fromer, G. Gregoratos, G. Klein, A. J. Moss, et al.
ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society
Europace,
September 1, 2006;
8(9):
746 - 837.
[Full Text]
[PDF]
|
|
|
|
|
|
|
E De Caro, F Fioredda, M G Calevo, A Smeraldi, M Saitta, G Hanau, M Faraci, F Grisolia, G Dini, G Pongiglione, et al.
Exercise capacity in apparently healthy survivors of cancer
Arch. Dis. Child.,
January 1, 2006;
91(1):
47 - 51.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. L. Y. Wong, V. A. Mukkada, L. W. Markham, and L. H. Cripe
Depressed Left Ventricular Contractile Reserve Diagnosed by Dobutamine Stress Echocardiography in a Patient With Duchenne Muscular Dystrophy
J Child Neurol,
March 1, 2005;
20(3):
246 - 248.
[Abstract]
[PDF]
|
|
|
|
|
|
|
L Hui, A K T Chau, M P Leung, C S W Chiu, and Y F Cheung
Assessment of left ventricular function long term after arterial switch operation for transposition of the great arteries by dobutamine stress echocardiography
Heart,
January 1, 2005;
91(1):
68 - 72.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. T.H. Yeh, A. T. Tong, D. J. Lenihan, S. W. Yusuf, J. Swafford, C. Champion, J.-B. Durand, H. Gibbs, A. A. Zafarmand, and M. S. Ewer
Cardiovascular Complications of Cancer Therapy: Diagnosis, Pathogenesis, and Management
Circulation,
June 29, 2004;
109(25):
3122 - 3131.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L Hui, M P Leung, S Y Ha, A K T Chau, and Y F Cheung
Early detection of left ventricular dysfunction in patients with {beta} thalassaemia major by dobutamine stress echocardiography
Heart,
June 1, 2003;
89(6):
669 - 670.
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. Jourdain, F. Funck, Y. Fulla, A. Hagege, M. Bellorini, N. Guillard, J. Loiret, B. Thebault, and M. Desnos
Myocardial contractile reserve under low doses of dobutamine and improvement of left ventricular ejection fraction with treatment by carvedilol
Eur J Heart Fail,
June 1, 2002;
4(3):
269 - 276.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. M. de Jong, J. H. Cornel, H. J.G.M. Crijns, and D. J. van Veldhuisen
Abnormal contractile responses during dobutamine stress echocardiography in patients with idiopathic dilated cardiomyopathy
Eur J Heart Fail,
August 1, 2001;
3(4):
429 - 436.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. R. Schwarz, C. Pollick, J. Dow, M. Patterson, Y. Birnbaum, and R. A. Kloner
A small animal model of non-ischemic cardiomyopathy and its evaluation by transthoracic echocardiography
Cardiovasc Res,
July 1, 1998;
39(1):
216 - 223.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. B. Kern, R. W. Hilwig, R. A. Berg, K. H. Rhee, A. B. Sanders, C. W. Otto, and G. A. Ewy
Postresuscitation Left Ventricular Systolic and Diastolic Dysfunction : Treatment With Dobutamine
Circulation,
June 17, 1997;
95(12):
2610 - 2613.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
J T Warner, W Bell, D K H Webb, and J W Gregory
Relationship between cardiopulmonary response to exercise and adiposity in survivors of childhood malignancy
Arch. Dis. Child.,
April 1, 1997;
76(4):
298 - 303.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
S. E. Lipshultz, S. R. Lipsitz, S. M. Mone, A. M. Goorin, S. E. Sallan, S. P. Sanders, E. J. Orav, R. D. Gelber, and S. D. Colan
Female Sex and Higher Drug Dose as Risk Factors for Late Cardiotoxic Effects of Doxorubicin Therapy for Childhood Cancer
N. Engl. J. Med.,
June 29, 1995;
332(26):
1738 - 1744.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Dunn
Doxorubicin-Induced Cardiomyopathy
Journal of Pediatric Oncology Nursing,
January 1, 1994;
11(4):
152 - 160.
[Abstract]
[PDF]
|
|
|
|
